MTOR and metabolic dysfunction-associated steatotic liver disease: Western blots revealed that compared with NAFLD mice, phosphorylation of AMPK was remarkably enhanced in hUC-MSC treated mice, followed by suppressed phosphorylation of mTOR (Fig. 6A).